Skip to content

Abivax

  • About Us
    • Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Overview
    • Publications
  • Pipeline
    • Overview
    • Patients
    • ABX464 for UC
    • ABX464 for Crohn’s
    • ABX464 for RA
    • ABX196 for HCC
  • News & Events
    • Press Releases
    • Press Coverage
    • Upcoming Events
  • Investors
    • Overview
    • Share Price
    • Investor Documents
    • Annual General Meeting
  • Contact Us
Search
  • EN
  • FR
  • DE

Investors

Annual General Meeting

The next Annual General Meeting will be held on June 4, 2021 at Dechert LLP in Paris (France). You find all the documents related to the Annual General Meeting below (all documents in French).

  • - Advance Notice of the Shareholders' Annual General Meeting (Update May 25, 2020)
  • - Advance Notice of the Shareholders' Annual General Meeting
  • - Notice of Convocation
  • - Text of the resolutions submitted on June 19, 2020
  • - Report of the Board of Directors to the Shareholders' Ordinary and Extraordinary GM as of June 19, 2020
  • - Information regarding the total number of voting rights and shares as of April 29, 2020
  • - Voting form for voting via mail or by proxy
  • - Auditor's Report - Resolution n° 12
  • - Auditor's Report - Resolution n° 15
  • - Auditor's Report - Resolution n° 23
  • - Auditor's Report - Resolution n° 24
  • - Auditor's Report - Resolution n° 25
  • - Auditor's Report - Resolution n° 27
  • - Auditor's Report - Resolution n°13, 14, 16, 17, 17, 18, 20, 21 and 22
  • - Universal Registration Document 2020
  • - Consolidated result for resolution vote (EGA & OGA)

Documents regarding the Annual General Meeting held on June 7, 2019 are available here.

Documents regarding the Annual General Meeting held on June 15, 2018 are available here.

Investor Contact

Chris Maggos LifeSci Advisors Chris@lifesciadvisors.com +41 79 367 6254
© 2021 All rights reserved by ABIVAX | Website created by DIGITAL VALLEE Privacy and Terms of Use
  • About Us
    • Company
    • Management Team
    • Board of Directors
    • Scientific Advisory Board
  • Science
    • Overview
    • Publications
  • Pipeline
    • ABX464 for UC
    • ABX464 for HIV
    • ABX196 for HCC
    • ABX544 for Ebola Virus
  • News & Events
    • Press Releases
    • Press Coverage
    • Upcoming Events
  • Investors
    • Share Profile
    • Share Price
    • Investor Documents
    • Analysts
    • Annual General Meeting
    • UEG Week 2019
Contact Us
  • Follow us on Twitter
  • Follow us on LinkedIn
  • Follow us on YouTube
  • Follow us on Google+